Àú³Î ȨÆäÀÌÁö
³í¹®Åõ°í±ÔÁ¤
  ÇÐȸÁö > ´ëÇÑÀÓ»óÅëÁõÇÐȸÁö °Ë»ö
20(02) 135-140
https://doi.org/10.35827/cp.2021.20.2.135
´ÙÇÑÁõ Ä¡·á ±â±¸ÀÎ MiraDry¿¡ ÀÇÇÑ ±ÙÇÇ ¹× Á¤Áß½Å°æ ¼Õ»ó Áõ·Ê
±è¿µ¹Î¤ýÀ±¹ÌÁ¤¤ý¹Ú¼±ÇϤý±è¹Î¿í
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÀÎõ¼º¸ðº´¿ø ÀçÈ°ÀÇÇб³½Ç
J Korean Assoc Pain Med 2021 Dec; 20(02) 135-140
Musculocutaneous and Median Neuropathy after MiraDry Procedure for Axillary Hyperhidrosis
Youngmin Kim, M.D., Mi-Jeong Yoon, M.D., Sunha Park, M.D. and Min Wook Kim, M.D., Ph.D.
Department of Rehabilitation Medicine, Incheon St. Mary¡¯s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
MiraDry®, a microwave thermolysis device, is comparably new non-surgical agent in the field of eradication of sweat glands for treating axillary hyperhidrosis and osmidrosis. So far, altered sensation, swelling, and compensatory sweating are widely known as adverse effects of MiraDry®. Of the few reported MiraDry®-induced neuropathy cases, median and ulnar neuropathies are common. Although, one case has described radial nerve and posterior cord damage with maximized stimulation intensity, musculocutaneous nerve damage induced by MiraDry® has not been reported. Here, we report a case of a 30-year-old woman experiencing left hand weakness after receiving MiraDry® at a local dermatology clinic. Left brachial plexopathy, mainly involving the median nerve and the musculocutaneous nerve with partial axonotmesis, was confirmed by electrodiagnostic studies. Ultrasound evaluation showed corresponding results. This is the first case report of the musculocutaneous neuropathy by MiraDry®.
J Korean Assoc Pain Med 2021 Dec; 20(02) 135-140
Keyword : MiraDry?, Musculocutaneous neuropathy, Ultrasound


[02447] ¼­¿ï µ¿´ë¹®±¸ °æÈñ´ë·Î 23 (ȸ±âµ¿) (°æÈñ´ëÇб³º´¿ø ÀçÈ°ÀÇÇаú ³»)
TEL : (¹®Àǽð£: 9½Ã-17½Ã) 02-958-8567 FAX : 02-958-8557 E-mail : kapainmed@hanmail.net
Copyright by The Korean Association of Pain Medicine. All rights reserved